These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35779656)

  • 41. Nanoparticle ligand presentation for targeting solid tumors.
    Duskey JT; Rice KG
    AAPS PharmSciTech; 2014 Oct; 15(5):1345-54. PubMed ID: 24927668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MMP-Responsive 'Smart' Drug Delivery and Tumor Targeting.
    Yao Q; Kou L; Tu Y; Zhu L
    Trends Pharmacol Sci; 2018 Aug; 39(8):766-781. PubMed ID: 30032745
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nano-therapeutics for modulating the tumour microenvironment: Design, development, and clinical translation.
    Adityan S; Tran M; Bhavsar C; Wu SY
    J Control Release; 2020 Nov; 327():512-532. PubMed ID: 32800879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor microenvironment targeting with dual stimuli-responsive nanoparticles based on small heat shock proteins for antitumor drug delivery.
    Shi K; Wang Y; Zhou X; Gui H; Xu N; Wu S; He C; Zhao Z
    Acta Biomater; 2020 Sep; 114():369-383. PubMed ID: 32688090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Emerging Strategies in Stimuli-Responsive Nanocarriers as the Drug Delivery System for Enhanced Cancer Therapy.
    Saravanakumar K; Hu X; Ali DM; Wang MH
    Curr Pharm Des; 2019; 25(24):2609-2625. PubMed ID: 31603055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor microenvironment dual-responsive core-shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA.
    Wang T; Yu X; Han L; Liu T; Liu Y; Zhang N
    Int J Nanomedicine; 2017; 12():4773-4788. PubMed ID: 28740384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent Advances in pH-Sensitive Polymeric Nanoparticles for Smart Drug Delivery in Cancer Therapy.
    Lim EK; Chung BH; Chung SJ
    Curr Drug Targets; 2018 Feb; 19(4):300-317. PubMed ID: 27262486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanotherapy Targeting the Tumor Microenvironment.
    Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
    Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges.
    Li W; Little N; Park J; Foster CA; Chen J; Lu J
    Mol Pharm; 2021 Aug; 18(8):2889-2905. PubMed ID: 34260250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
    Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanoparticles Targeting Receptors on Breast Cancer for Efficient Delivery of Chemotherapeutics.
    Jahan S; Karim ME; Chowdhury EH
    Biomedicines; 2021 Jan; 9(2):. PubMed ID: 33530291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor microenvironment-responsive size-switchable drug delivery nanosystems.
    Hu Y; Gao S; Khan AR; Yang X; Ji J; Xi Y; Zhai G
    Expert Opin Drug Deliv; 2022 Mar; 19(3):221-234. PubMed ID: 35164610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment.
    Ashfaq UA; Riaz M; Yasmeen E; Yousaf MZ
    Crit Rev Ther Drug Carrier Syst; 2017; 34(4):317-353. PubMed ID: 29199588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nanoparticles Targeting and Remodeling Tumor Microenvironment for Cancer Theranostics.
    Lin G; Chen S; Mi P
    J Biomed Nanotechnol; 2018 Jul; 14(7):1189-1207. PubMed ID: 29944095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics.
    Steichen SD; Caldorera-Moore M; Peppas NA
    Eur J Pharm Sci; 2013 Feb; 48(3):416-27. PubMed ID: 23262059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual targeting smart drug delivery system for multimodal synergistic combination cancer therapy with reduced cardiotoxicity.
    Shubhra QTH; Guo K; Liu Y; Razzak M; Serajum Manir M; Moshiul Alam AKM
    Acta Biomater; 2021 Sep; 131():493-507. PubMed ID: 34139367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumor targeting antibody-conjugated nanocarrier with pH/thermo dual-responsive macromolecular film layer for enhanced cancer chemotherapy.
    Zhuang J; Zhou L; Tang W; Ma T; Li H; Wang X; Chen C; Wang P
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111361. PubMed ID: 33254980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance.
    Hu M; Huang L
    Adv Drug Deliv Rev; 2022 Apr; 183():114137. PubMed ID: 35143893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles.
    Yan G; Wang J; Hu L; Wang X; Yang G; Fu S; Cheng X; Zhang P; Tang R
    Acta Biomater; 2017 Mar; 51():363-373. PubMed ID: 28087485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Weak Link: Optimization of the Ligand-Nanoparticle Interface To Enhance Cancer Cell Targeting by Polymer Micelles.
    Wang J; Dzuricky M; Chilkoti A
    Nano Lett; 2017 Oct; 17(10):5995-6005. PubMed ID: 28853896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.